Literature DB >> 20966618

Incidence and risk factors for early postoperative cognitive decline after coronary artery bypass grafting.

Ieva Norkienė1, Robertas Samalavičius, Irina Misiūrienė, Kotryna Paulauskienė, Valmantas Budrys, Juozas Ivaškevičius.   

Abstract

BACKGROUND. The aim of our study was to evaluate the incidence of early postoperative cognitive decline (POCD) and determine perioperative risk factors as well as the impact of asymptomatic cerebral vascular lesion on the development of neurocognitive complications. MATERIALS AND METHODS. A total of 127 consecutive adult patients undergoing on-pump coronary artery bypass grafting were studied. Neuropsychological testing was performed the day before surgery and 7-9 days after operation. Stepwise logistic regression analysis determined independent predictors of POCD. RESULTS. The incidence of postoperative cognitive decline was 46% (n=59). Patients in the POCD group were older (P=0.04) and had an increased prevalence of asymptomatic carotid artery stenosis (P=0.0001). POCD was associated with longer time in surgery (P=0.018), inotropic support intraoperativelly (P=0.02) and during postoperative period (P=0.008). Patients in the POCD group had an increased incidence of postoperative bleeding (P=0.037), delirium (P=0.016) and stayed in hospital for a longer period (P=0.007). Age of more than 65 years (OR, 2.7), asymptomatic carotid artery stenosis of more than 50% (OR, 26.89), duration of surgery of more than 4 hours (OR, 4.08), postoperative mechanical ventilation of more than 6 hours (OR, 3.33), and stay in an intensive care unit for more than 3 days (OR, 3.38) were significant independent predictors of cognitive decline. CONCLUSIONS. Increased age, preoperative prevalence of craniocervical atherosclerotic lesions, longer time in surgery, longer stay in an intensive care unit and mechanical ventilation time were found to be the risk factors for developing postoperative cognitive decline.

Entities:  

Mesh:

Year:  2010        PMID: 20966618

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  8 in total

1.  Factors associated with post-surgical delirium in patients undergoing open heart surgery.

Authors:  Yadollah Jannati; Masoumeh Bagheri-Nesami; Maryam Sohrabi; Jamshid Yazdani-Cherati; Shahrzad Mazdarani
Journal:  Oman Med J       Date:  2014-09

2.  Oxycodone induced delirium and agitation in an elderly patient following total right knee arthroplasty.

Authors:  Joseph H Crane; Katie J Suda
Journal:  Int J Clin Pharm       Date:  2011-08-19

3.  Dexmedetomidine alleviates postoperative cognitive dysfunction by inhibiting neuron excitation in aged rats.

Authors:  Bo Xiong; Qiqing Shi; Hao Fang
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

4.  Electric vagal nerve stimulation inhibits inflammation and improves early postoperation cognitive dysfunction in aged rats.

Authors:  Jun Xiong; Huijun Wang; Yin Bao; Yuliang Guo; Yongxing Sun
Journal:  BMC Anesthesiol       Date:  2019-11-23       Impact factor: 2.217

5.  Hypertension and Risk of Post-Operative Cognitive Dysfunction (POCD): A Systematic Review and Meta-Analysis.

Authors:  I Feinkohl; G Winterer; T Pischon
Journal:  Clin Pract Epidemiol Ment Health       Date:  2017-05-18

6.  Electroacupuncture reduces astrocyte number and oxidative stress in aged rats with surgery-induced cognitive dysfunction.

Authors:  Pei-Rong Liu; Feng Cao; Yu Zhang; Sheng Peng
Journal:  J Int Med Res       Date:  2019-07-16       Impact factor: 1.671

7.  Prevention of Cognitive Dysfunction after Cataract Surgery with Intravenous Administration of Midazolam and Dexmedetomidine in Elderly Patients Undergoing Cataract Surgery.

Authors:  Neda Mansouri; Kobra Nasrollahi; Hamidreza Shetabi
Journal:  Adv Biomed Res       Date:  2019-01-31

8.  Effects of Omega-3 Polyunsaturated Fatty Acids on Cognitive Function after Splenectomy in Rats.

Authors:  Yong Guo; Feng Ping; Yongmei Cao; Jiawei Shang; Junfeng Zhang; Hong Jiang; Shudong Fang
Journal:  Biomed Res Int       Date:  2021-12-26       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.